These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2694113)

  • 1. Pharmacokinetics of felbamate, a novel antiepileptic drug: application of mixed-effect modeling to clinical trials.
    Graves NM; Ludden TM; Holmes GB; Fuerst RH; Leppik IE
    Pharmacotherapy; 1989; 9(6):372-6. PubMed ID: 2694113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of age on the apparent clearance of felbamate: a retrospective analysis using nonlinear mixed-effects modeling.
    Banfield CR; Zhu GR; Jen JF; Jensen PK; Schumaker RC; Perhach JL; Affrime MB; Glue P
    Ther Drug Monit; 1996 Feb; 18(1):19-29. PubMed ID: 8848816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of felbamate in children.
    Kelley MT; Walson PD; Cox S; Dusci LJ
    Ther Drug Monit; 1997 Feb; 19(1):29-36. PubMed ID: 9029743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
    Graves NM; Holmes GB; Fuerst RH; Leppik IE
    Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Felbamate: a new antiepileptic drug.
    Wagner ML
    Am J Hosp Pharm; 1994 Jul; 51(13):1657-66. PubMed ID: 7942890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsy.
    Sachdeo RC; Narang-Sachdeo S; Montgomery PA; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
    J Clin Pharmacol; 1998 Feb; 38(2):184-90. PubMed ID: 9549651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
    Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
    Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose pharmacokinetics of felbamate in patients with renal dysfunction.
    Glue P; Sulowicz W; Colucci R; Banfield C; Pai S; Lin C; Affrime MB
    Br J Clin Pharmacol; 1997 Jul; 44(1):91-3. PubMed ID: 9241102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single and multiple dose pharmacokinetics of felbamate in the elderly.
    Richens A; Banfield CR; Salfi M; Nomeir A; Lin CC; Jensen P; Affrime MB; Glue P
    Br J Clin Pharmacol; 1997 Aug; 44(2):129-34. PubMed ID: 9278196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of felbamate in pediatric and adult beagle dogs.
    Adusumalli VE; Gilchrist JR; Wichmann JK; Kucharczyk N; Sofia RD
    Epilepsia; 1992; 33(5):955-60. PubMed ID: 1396441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of felbamate on carbamazepine and its major metabolites.
    Wagner ML; Remmel RP; Graves NM; Leppik IE
    Clin Pharmacol Ther; 1993 May; 53(5):536-43. PubMed ID: 8491065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interaction studies between felbamate and vigabatrin.
    Reidenberg P; Glue P; Banfield C; Colucci R; Meehan J; Rey E; Radwanski E; Nomeir A; Lim J; Lin C
    Br J Clin Pharmacol; 1995 Aug; 40(2):157-60. PubMed ID: 8562299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential pharmacokinetic interaction between felbamate and phenobarbital.
    Gidal BE; Zupanc ML
    Ann Pharmacother; 1994 Apr; 28(4):455-8. PubMed ID: 8038465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of carbamazepine in adults with epilepsy.
    Graves NM; Brundage RC; Wen Y; Cascino G; So E; Ahman P; Rarick J; Krause S; Leppik IE
    Pharmacotherapy; 1998; 18(2):273-81. PubMed ID: 9545146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of felbamate in therapy for partial epilepsy in children.
    Carmant L; Holmes GL; Sawyer S; Rifai N; Anderson J; Mikati MA
    J Pediatr; 1994 Sep; 125(3):481-6. PubMed ID: 8071763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation.
    Glue P; Banfield CR; Perhach JL; Mather GG; Racha JK; Levy RH
    Clin Pharmacokinet; 1997 Sep; 33(3):214-24. PubMed ID: 9314612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation.
    Hooper WD; Franklin ME; Glue P; Banfield CR; Radwanski E; McLaughlin DB; McIntyre ME; Dickinson RG; Eadie MJ
    Epilepsia; 1996 Jan; 37(1):91-7. PubMed ID: 8603632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine pharmacokinetics in patients receiving felbamate.
    Gidal BE; Kanner A; Maly M; Rutecki P; Lensmeyer GL
    Epilepsy Res; 1997 Apr; 27(1):1-5. PubMed ID: 9169285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine.
    Hulsman JA; Rentmeester TW; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Radwanski E; Mojaverian P; Lin CC; Nezamis J
    Clin Pharmacol Ther; 1995 Oct; 58(4):383-9. PubMed ID: 7586929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isothermal gas chromatographic method for the rapid determination of felbamate concentration in human serum.
    Poquette MA
    Ther Drug Monit; 1995 Apr; 17(2):168-73. PubMed ID: 7624905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.